Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome
Identifieur interne : 003463 ( Istex/Corpus ); précédent : 003462; suivant : 003464Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome
Auteurs : Burton L. Scott ; Jankovic ; Donald T. DonovanSource :
- Movement Disorders [ 0885-3185 ] ; 1996-07.
English descriptors
- KwdEn :
Abstract
We describe a 13‐year‐old boy with Tourette's syndrome (TS) manifested chiefly by severe coprolalia, obsessive compulsive disorder, and attention deficit hyperactivity disorder. He was treated with unilateral injections of botulinum toxin to the vocal cord and experienced marked improvement in coprolalia as well as marked reduction in the premonitory urges associated with the vocal tics and coprolalia. As a result of the improvement, the patient was able to attend school and church and was able to socialize. Botulinum toxin may interfere with a sensory reflex are required to perpetuate tics and coprolalia in TS, possibly by reducing local build‐up of tension or muscle contraction in affected areas.
Url:
DOI: 10.1002/mds.870110413
Links to Exploration step
ISTEX:6C664A0C434AF7C2E6C7348FAEDCC9982D352CC1Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome</title><author><name sortKey="Scott, Burton L" sort="Scott, Burton L" uniqKey="Scott B" first="Burton L." last="Scott">Burton L. Scott</name><affiliation><mods:affiliation>Parkinson's Disease Center and Movement Disorder Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas, U.S.A.</mods:affiliation></affiliation></author><author><name sortKey="Jankovic" sort="Jankovic" uniqKey="Jankovic" last="Jankovic">Jankovic</name><affiliation><mods:affiliation>Parkinson's Disease Center and Movement Disorder Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas, U.S.A.</mods:affiliation></affiliation></author><author><name sortKey="Donovan, Donald T" sort="Donovan, Donald T" uniqKey="Donovan D" first="Donald T." last="Donovan">Donald T. Donovan</name><affiliation><mods:affiliation>Department of Otorhinolaryngology, Baylor College of Medicine, Houston, Texas, U.S.A.</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:6C664A0C434AF7C2E6C7348FAEDCC9982D352CC1</idno><date when="1996" year="1996">1996</date><idno type="doi">10.1002/mds.870110413</idno><idno type="url">https://api.istex.fr/document/6C664A0C434AF7C2E6C7348FAEDCC9982D352CC1/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">003463</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome</title><author><name sortKey="Scott, Burton L" sort="Scott, Burton L" uniqKey="Scott B" first="Burton L." last="Scott">Burton L. Scott</name><affiliation><mods:affiliation>Parkinson's Disease Center and Movement Disorder Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas, U.S.A.</mods:affiliation></affiliation></author><author><name sortKey="Jankovic" sort="Jankovic" uniqKey="Jankovic" last="Jankovic">Jankovic</name><affiliation><mods:affiliation>Parkinson's Disease Center and Movement Disorder Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas, U.S.A.</mods:affiliation></affiliation></author><author><name sortKey="Donovan, Donald T" sort="Donovan, Donald T" uniqKey="Donovan D" first="Donald T." last="Donovan">Donald T. Donovan</name><affiliation><mods:affiliation>Department of Otorhinolaryngology, Baylor College of Medicine, Houston, Texas, U.S.A.</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="1996-07">1996-07</date><biblScope unit="vol">11</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="431">431</biblScope><biblScope unit="page" to="433">433</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">6C664A0C434AF7C2E6C7348FAEDCC9982D352CC1</idno><idno type="DOI">10.1002/mds.870110413</idno><idno type="ArticleID">MDS870110413</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Attention deficit hyperacitivity disorder</term><term>Botulinum toxin</term><term>Coprolalia</term><term>Obsessive compulsive disorder</term><term>Tics</term><term>Tourette's syndrome</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We describe a 13‐year‐old boy with Tourette's syndrome (TS) manifested chiefly by severe coprolalia, obsessive compulsive disorder, and attention deficit hyperactivity disorder. He was treated with unilateral injections of botulinum toxin to the vocal cord and experienced marked improvement in coprolalia as well as marked reduction in the premonitory urges associated with the vocal tics and coprolalia. As a result of the improvement, the patient was able to attend school and church and was able to socialize. Botulinum toxin may interfere with a sensory reflex are required to perpetuate tics and coprolalia in TS, possibly by reducing local build‐up of tension or muscle contraction in affected areas.</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Burton L. Scott</name><affiliations><json:string>Parkinson's Disease Center and Movement Disorder Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas, U.S.A.</json:string></affiliations></json:item><json:item><name>Dr. Jankovic</name><affiliations><json:string>Parkinson's Disease Center and Movement Disorder Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas, U.S.A.</json:string></affiliations></json:item><json:item><name>Donald T. Donovan</name><affiliations><json:string>Department of Otorhinolaryngology, Baylor College of Medicine, Houston, Texas, U.S.A.</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Tourette's syndrome</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Tics</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Coprolalia</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Obsessive compulsive disorder</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Attention deficit hyperacitivity disorder</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Botulinum toxin</value></json:item></subject><language><json:string>eng</json:string></language><abstract>We describe a 13‐year‐old boy with Tourette's syndrome (TS) manifested chiefly by severe coprolalia, obsessive compulsive disorder, and attention deficit hyperactivity disorder. He was treated with unilateral injections of botulinum toxin to the vocal cord and experienced marked improvement in coprolalia as well as marked reduction in the premonitory urges associated with the vocal tics and coprolalia. As a result of the improvement, the patient was able to attend school and church and was able to socialize. Botulinum toxin may interfere with a sensory reflex are required to perpetuate tics and coprolalia in TS, possibly by reducing local build‐up of tension or muscle contraction in affected areas.</abstract><qualityIndicators><score>3.286</score><pdfVersion>1.3</pdfVersion><pdfPageSize>576 x 792 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractCharCount>707</abstractCharCount><pdfWordCount>2002</pdfWordCount><pdfCharCount>12501</pdfCharCount><pdfPageCount>3</pdfPageCount><abstractWordCount>107</abstractWordCount></qualityIndicators><title>Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome</title><genre><json:string>Serial article</json:string></genre><host><volume>11</volume><pages><total>3</total><last>433</last><first>431</first></pages><issn><json:string>0885-3185</json:string></issn><issue>4</issue><subject><json:item><value>Brief Report</value></json:item></subject><genre></genre><language><json:string>unknown</json:string></language><title>Movement Disorders</title><doi><json:string>10.1002/(ISSN)1531-8257</json:string></doi></host><publicationDate>1996</publicationDate><copyrightDate>1996</copyrightDate><doi><json:string>10.1002/mds.870110413</json:string></doi><id>6C664A0C434AF7C2E6C7348FAEDCC9982D352CC1</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/6C664A0C434AF7C2E6C7348FAEDCC9982D352CC1/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/6C664A0C434AF7C2E6C7348FAEDCC9982D352CC1/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/6C664A0C434AF7C2E6C7348FAEDCC9982D352CC1/fulltext/tei"><teiHeader type="text"><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><availability><p>Wiley Subscription Services, Inc., A Wiley Company</p></availability><date>1996</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome</title><author><persName><forename type="first">Burton L.</forename><surname>Scott</surname></persName><affiliation>Parkinson's Disease Center and Movement Disorder Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas, U.S.A.</affiliation></author><author><persName><surname>Jankovic</surname><roleName type="degree">Dr.</roleName></persName><note type="correspondence"><p>Correspondence: Deparment of Neurology, Baylor College of Medicine, 6550 Fannin,# 1801, Houston, TX7030, U.S.A.</p></note><affiliation>Parkinson's Disease Center and Movement Disorder Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas, U.S.A.</affiliation></author><author><persName><forename type="first">Donald T.</forename><surname>Donovan</surname></persName><affiliation>Department of Otorhinolaryngology, Baylor College of Medicine, Houston, Texas, U.S.A.</affiliation></author></analytic><monogr><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="pISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><idno type="DOI">10.1002/(ISSN)1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="1996-07"></date><biblScope unit="vol">11</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="431">431</biblScope><biblScope unit="page" to="433">433</biblScope></imprint></monogr><idno type="istex">6C664A0C434AF7C2E6C7348FAEDCC9982D352CC1</idno><idno type="DOI">10.1002/mds.870110413</idno><idno type="ArticleID">MDS870110413</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>1996</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>We describe a 13‐year‐old boy with Tourette's syndrome (TS) manifested chiefly by severe coprolalia, obsessive compulsive disorder, and attention deficit hyperactivity disorder. He was treated with unilateral injections of botulinum toxin to the vocal cord and experienced marked improvement in coprolalia as well as marked reduction in the premonitory urges associated with the vocal tics and coprolalia. As a result of the improvement, the patient was able to attend school and church and was able to socialize. Botulinum toxin may interfere with a sensory reflex are required to perpetuate tics and coprolalia in TS, possibly by reducing local build‐up of tension or muscle contraction in affected areas.</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>Tourette's syndrome</term></item><item><term>Tics</term></item><item><term>Coprolalia</term></item><item><term>Obsessive compulsive disorder</term></item><item><term>Attention deficit hyperacitivity disorder</term></item><item><term>Botulinum toxin</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>Article category</head><item><term>Brief Report</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="1995-12-22">Registration</change><change when="1996-07">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/6C664A0C434AF7C2E6C7348FAEDCC9982D352CC1/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName><publisherLoc>Hoboken</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1531-8257</doi><issn type="print">0885-3185</issn><issn type="electronic">1531-8257</issn><idGroup><id type="product" value="MDS"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title><title type="subtitle">Official Journal of the Movement Disorder Society</title><title type="short">Mov. Disord.</title></titleGroup></publicationMeta><publicationMeta level="part" position="40"><doi origin="wiley" registered="yes">10.1002/mds.v11:4</doi><numberingGroup><numbering type="journalVolume" number="11">11</numbering><numbering type="journalIssue">4</numbering></numberingGroup><coverDate startDate="1996-07">July 1996</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="13" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.870110413</doi><idGroup><id type="unit" value="MDS870110413"></id></idGroup><countGroup><count type="pageTotal" number="3"></count></countGroup><titleGroup><title type="articleCategory">Brief Report</title><title type="tocHeading1">Brief Reports</title></titleGroup><copyright ownership="thirdParty">Copyright © 1996 Movement Disorder Society</copyright><eventGroup><event type="manuscriptAccepted" date="1995-12-22"></event><event type="firstOnline" date="2004-11-04"></event><event type="publishedOnlineFinalForm" date="2004-11-04"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.2 mode:FullText source:HeaderRef result:HeaderRef" date="2010-03-09"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event></eventGroup><numberingGroup><numbering type="pageFirst">431</numbering><numbering type="pageLast">433</numbering></numberingGroup><correspondenceTo>Deparment of Neurology, Baylor College of Medicine, 6550 Fannin,# 1801, Houston, TX7030, U.S.A.</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:MDS.MDS870110413.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="0"></count><count type="tableTotal" number="0"></count><count type="referenceTotal" number="15"></count></countGroup><titleGroup><title type="main" xml:lang="en">Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome</title><title type="short" xml:lang="en">BOTULINUM TOXIN IN TOURETTE'S SYNDROME</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Burton L.</givenNames><familyName>Scott</familyName></personName></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><honorifics>Dr.</honorifics><givenNames>Joseph</givenNames><familyName>Jankovic</familyName></personName></creator><creator xml:id="au3" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Donald T.</givenNames><familyName>Donovan</familyName></personName></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="US" type="organization"><unparsedAffiliation>Parkinson's Disease Center and Movement Disorder Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas, U.S.A.</unparsedAffiliation></affiliation><affiliation xml:id="af2" countryCode="US" type="organization"><unparsedAffiliation>Department of Otorhinolaryngology, Baylor College of Medicine, Houston, Texas, U.S.A.</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">Tourette's syndrome</keyword><keyword xml:id="kwd2">Tics</keyword><keyword xml:id="kwd3">Coprolalia</keyword><keyword xml:id="kwd4">Obsessive compulsive disorder</keyword><keyword xml:id="kwd5">Attention deficit hyperacitivity disorder</keyword><keyword xml:id="kwd6">Botulinum toxin</keyword></keywordGroup><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>We describe a 13‐year‐old boy with Tourette's syndrome (TS) manifested chiefly by severe coprolalia, obsessive compulsive disorder, and attention deficit hyperactivity disorder. He was treated with unilateral injections of botulinum toxin to the vocal cord and experienced marked improvement in coprolalia as well as marked reduction in the premonitory urges associated with the vocal tics and coprolalia. As a result of the improvement, the patient was able to attend school and church and was able to socialize. Botulinum toxin may interfere with a sensory reflex are required to perpetuate tics and coprolalia in TS, possibly by reducing local build‐up of tension or muscle contraction in affected areas.</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><!--Version 0.6 générée le 4-12-2015--><mods version="3.6"><titleInfo lang="en"><title>Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>BOTULINUM TOXIN IN TOURETTE'S SYNDROME</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome</title></titleInfo><name type="personal"><namePart type="given">Burton L.</namePart><namePart type="family">Scott</namePart><affiliation>Parkinson's Disease Center and Movement Disorder Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas, U.S.A.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="termsOfAddress">Dr.</namePart><namePart type="family">Jankovic</namePart><affiliation>Parkinson's Disease Center and Movement Disorder Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas, U.S.A.</affiliation><description>Correspondence: Deparment of Neurology, Baylor College of Medicine, 6550 Fannin,# 1801, Houston, TX7030, U.S.A.</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Donald T.</namePart><namePart type="family">Donovan</namePart><affiliation>Department of Otorhinolaryngology, Baylor College of Medicine, Houston, Texas, U.S.A.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre authority="originalCategForm">article</genre><originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><place><placeTerm type="text">Hoboken</placeTerm></place><dateIssued encoding="w3cdtf">1996-07</dateIssued><dateValid encoding="w3cdtf">1995-12-22</dateValid><copyrightDate encoding="w3cdtf">1996</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="references">15</extent></physicalDescription><abstract lang="en">We describe a 13‐year‐old boy with Tourette's syndrome (TS) manifested chiefly by severe coprolalia, obsessive compulsive disorder, and attention deficit hyperactivity disorder. He was treated with unilateral injections of botulinum toxin to the vocal cord and experienced marked improvement in coprolalia as well as marked reduction in the premonitory urges associated with the vocal tics and coprolalia. As a result of the improvement, the patient was able to attend school and church and was able to socialize. Botulinum toxin may interfere with a sensory reflex are required to perpetuate tics and coprolalia in TS, possibly by reducing local build‐up of tension or muscle contraction in affected areas.</abstract><subject lang="en"><genre>Keywords</genre><topic>Tourette's syndrome</topic><topic>Tics</topic><topic>Coprolalia</topic><topic>Obsessive compulsive disorder</topic><topic>Attention deficit hyperacitivity disorder</topic><topic>Botulinum toxin</topic></subject><relatedItem type="host"><titleInfo><title>Movement Disorders</title><subTitle>Official Journal of the Movement Disorder Society</subTitle></titleInfo><titleInfo type="abbreviated"><title>Mov. Disord.</title></titleInfo><subject><genre>article category</genre><topic>Brief Report</topic></subject><identifier type="ISSN">0885-3185</identifier><identifier type="eISSN">1531-8257</identifier><identifier type="DOI">10.1002/(ISSN)1531-8257</identifier><identifier type="PublisherID">MDS</identifier><part><date>1996</date><detail type="volume"><caption>vol.</caption><number>11</number></detail><detail type="issue"><caption>no.</caption><number>4</number></detail><extent unit="pages"><start>431</start><end>433</end><total>3</total></extent></part></relatedItem><identifier type="istex">6C664A0C434AF7C2E6C7348FAEDCC9982D352CC1</identifier><identifier type="DOI">10.1002/mds.870110413</identifier><identifier type="ArticleID">MDS870110413</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 1996 Movement Disorder Society</accessCondition><recordInfo><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin><recordContentSource>WILEY</recordContentSource></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003463 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 003463 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:6C664A0C434AF7C2E6C7348FAEDCC9982D352CC1
|texte= Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome
}}
| This area was generated with Dilib version V0.6.23. |  |